Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
Joint Authors
Ribaldone, Davide Giuseppe
Astegiano, Marco
Source
Gastroenterology Research and Practice
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-12-16
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Recently, Sue et al.
published an open-label study, aiming to assess the efficacy of a 7-day first-line Helicobacter pylori (H.
pylori) eradication regimen with vonoprazan (VPZ), clarithromycin (CAM), and metronidazole (MNZ), in patients with penicillin allergy [1].
In a letter to the editor, Kashani and Abadi raised several criticisms of this article [2].
The authors responded [3], but we want to focus on two not redundant points.
American Psychological Association (APA)
Ribaldone, Davide Giuseppe& Astegiano, Marco. 2018. Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”. Gastroenterology Research and Practice،Vol. 2018, no. 2018, pp.1-2.
https://search.emarefa.net/detail/BIM-1165053
Modern Language Association (MLA)
Ribaldone, Davide Giuseppe& Astegiano, Marco. Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”. Gastroenterology Research and Practice No. 2018 (2018), pp.1-2.
https://search.emarefa.net/detail/BIM-1165053
American Medical Association (AMA)
Ribaldone, Davide Giuseppe& Astegiano, Marco. Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”. Gastroenterology Research and Practice. 2018. Vol. 2018, no. 2018, pp.1-2.
https://search.emarefa.net/detail/BIM-1165053
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1165053
